We create simulations that capture disease biology to move your pipeline forward, with confidence. Know the efficacy and safety profile of your drug before facing late-stage failures.

Disease models to predict the % probability of target efficacy.

Explore higher order features to predict patient responders.

Versatile data visualization suite to transform complex data into actionable biological insights.

Calculate the molecular efficacy of your target or combination of targets.

Insights to drive key decisions during drug development.

Predict new molecular interactions previously unknown.

Prioritize drug targets in your pipeline and compare to targets in the competitive landscape.

Identify signatures more predictive of drug response than single transcripts.

Accurately stratify patients to find the right subgroups to meet Phase II/III endpoints, the first time.

Contextualization of differentially-expressed genes or proteins within physiological networks.

Disease agnostic approach for analysis of differential protein expression across varying conditions.

Intuitive display of data analyses to maximize useful insights.

Easy data pre-processing, analysis and visualization.

Choosing Simmunome's platform enables clients to harness the power of precision medicine, data integration, and advanced analytics, ultimately leading to improved patient outcomes and accelerated research discoveries.

AI models boost our algorithm’s capabilities by augmenting the biological knowledge available.

Models safely leverage your own custom data to get results targeted for your specific needs.

No one can access the network unless they are authenticated. We rely on Auth0 and JWTs to ensure online safety.

Plug and play platform providing reliable insights without the need for any AI expertise.

Our unique approach combines mechanistic modeling and machine learning algorithms. Abiding by biological rules, it surpasses traditional methods and pure data-driven approaches in reliability.

Enabling clients to trace results to every interaction that influences calculated efficacy or safety profiles.

Development of disease models across different therapeutic areas, allowing for comparisons across diseases and swift pivoting to indications with greatest potential.

Whether it’s a turn-key solution for autonomous analysis or a customized approach, Simmunome is there to provide fast, accurate results to make key go/no-go decisions about your pipeline.

Simmunome’s BioTarget™ Scoring Tool predicts the efficacy response of inhibiting, or activating, a target by tracing the biological pathways leading to disease endpoints.  We simulated disease pathways and used the protein geometric structure to calculate an efficacy score and range. Efficacy scores were compared to the observed efficacy response ranges of previously completed clinical trials – successful or not – to see how we measured up.